Medical specialists from France tagged as investigators in clinical trials studying Clear Cell Renal Cell Carcinoma
Total 91 results
-
Alexis LEPINOY, MDSeen in:
- Dijon, Institut de cancérologie de Bourgogne (Dijon, Auxerre, Chalon sur Saône)
Trials:- NCT04299646 (Principal Investigator)
Conditions: -
Alexis VALLARD, MDSeen in:
- Saint-Priest-en-Jarez, ICLN - département de radiothérapie
- Saint-Étienne, Institut de Cancérologie de la Loire Lucien Neuwirth
Trials:- NCT03866785 (Sub-Investigator)
- NCT04299646 (Sub-Investigator)
Conditions: -
Ali HASBINI, MDSeen in:
- Brest, Clilnique Pasteur
Trials:- NCT04764487 (Principal Investigator)
Conditions: -
ANAIS STEFANI, MDSeen in:
- Nancy, Institut de Cancérologie de Lorraine
- Vandœuvre-lès-Nancy, Institut de Cancérologie de Lorraine Alexis Vautrin
Trials:- NCT03818386 (Principal Investigator)
- NCT04299646 (Principal Investigator)
-
Anne-Sophie BAUMANN, MDSeen in:
- Nancy, Institut de Cancérologie de Lorraine
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Antoine THIERY-VUILLEMIN, MDSeen in:
- Besançon, CHU Jean Minjoz
Trials:- NCT04764487 (Principal Investigator)
Conditions: -
Bénédicte HENRIQUES, MDSeen in:
- Bordeaux, Radiothérapie Bordeaux Nord Aquitaine
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Benjamin SCHIPMAN, MDSeen in:
- Dijon, Institut de cancérologie de Bourgogne (Dijon, Auxerre, Chalon sur Saône)
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Bérengère NARCISO, MDSeen in:
- Tours, CHU Bretonneau
Trials:- NCT04764487 (Principal Investigator)
Conditions: -
Bertrand FLEURY, MDSeen in:
- Valence, Centre Marie Curie
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Carmen LLACER-MOSCARDO, MDSeen in:
- Montpellier, ICM
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Cécile VICIER, MDSeen in:
- Lyon, Centre LEON BERARD
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Christine CHEVREAU, MDSeen in:
- Toulouse, Institut Claudius Regaud
- Toulouse, Iuct-Oncopole Institut Claudius Regaud
Trials:- NCT02389244 (Principal Investigator)
- NCT05096390 (Principal Investigator)
-
Claude ALZIEU, MDSeen in:
- Albi, Clinique Claude Bernard
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
David AZRIA, PhDSeen in:
- Montpellier, ICM
Trials:- NCT04299646 (Principal Investigator)
Conditions: -
Delphine BORCHIELLINI, MDSeen in:
- AM, Nice Cedex 2, Centre Antoine-Lacassagne
- Nice, Centre Antoine Lacassagne
Trials:- NCT05551117 (Principal Investigator)
- NCT04678362 (Principal Investigator)
- NCT05096390 (Principal Investigator)
Conditions:- Melanoma;
- Non-small Cell Lung Cancer;
- Small-cell Lung Cancer;
- Head and Neck Squamous Cell Carcinoma;
- Anal Cancer;
- Malignant Melanoma;
- Non-small Cell Carcinoma;
- Oral Squamous Cell Carcinoma;
- Small Cell Carcinoma;
- Laryngeal Squamous Cell Carcinoma;
- Carcinoma, Squamous Cell of Head and Neck;
- Castration-Resistant Prostatic Cancer;
- Androgen-Independent Prostatic Cancer;
- Androgen-Insensitive Prostatic Cancer;
- Androgen-Resistant Prostatic Cancer;
- Hormone Refractory Prostatic Cancer;
- Anal Neoplasm;
- Urothelial Carcinoma;
- Papillary Renal Cell Carcinoma Type 2
-
Diego TOSI, MDSeen in:
- Montpellier, ICM
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Elodie COQUAN, MDSeen in:
- Caen, Centre Francois Baclesse
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Emilie BONNET, MDSeen in:
- Valence, Centre Marie Curie
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Emmanuel MEYER, MDSeen in:
- Caen, Centre Francois Baclesse
Trials:- NCT04299646 (Principal Investigator)
Conditions: -
Emmanuel RIO, MDSeen in:
- Nantes, Institut de Cancérologie de l'Ouest
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Eric LECHEVALLIER, MDSeen in:
- Marseille, CHU La Timone
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Fabien CALCAGNO, MDSeen in:
- Besançon, CHU Jean Minjoz
- Besançon, CHU de Besancon
Trials:- NCT04268121 (Principal Investigator)
- NCT05096390 (Principal Investigator)
-
Florence JOLY, PhDSeen in:
- Caen, Centre Francois Baclesse
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
François GUICHARD, MDSeen in:
- Bordeaux, Radiothérapie Bordeaux Nord Aquitaine
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Frank PRIOU, MDSeen in:
- La Roche-sur-Yon, CHD Vendee
Trials:- NCT04764487 (Principal Investigator)
Conditions: -
Fréderic ROLLAND, MDSeen in:
- Saint-Herblain, Co-Rene Gauducheau
- Saint-Herblain, Ico-Rene Gauducheau
Trials:- NCT05096390 (Principal Investigator)
Conditions: -
Friederike Schlurmann, MDSeen in:
- Brest, CHRU Brest
Trials:- NCT05551117 (Principal Investigator)
- NCT04764487 (Principal Investigator)
Conditions:- Melanoma;
- Non-small Cell Lung Cancer;
- Small-cell Lung Cancer;
- Head and Neck Squamous Cell Carcinoma;
- Anal Cancer;
- Malignant Melanoma;
- Non-small Cell Carcinoma;
- Oral Squamous Cell Carcinoma;
- Small Cell Carcinoma;
- Laryngeal Squamous Cell Carcinoma;
- Carcinoma, Squamous Cell of Head and Neck;
- Castration-Resistant Prostatic Cancer;
- Androgen-Independent Prostatic Cancer;
- Androgen-Insensitive Prostatic Cancer;
- Androgen-Resistant Prostatic Cancer;
- Hormone Refractory Prostatic Cancer;
- Anal Neoplasm;
- Renal Cell Carcinoma Metastatic
-
Gabriel MALOUF, MDSeen in:
- Strasbourg, Hôpitaux Universitaires de Strasbourg
Trials:- NCT04764487 (Principal Investigator)
Conditions: -
Gabriele CORAGGIO, MDSeen in:
- Créteil, CHU Henri Mondor
Trials:- NCT04299646 (Sub-Investigator)
Conditions:
Clinical Trials on Clear Cell Renal Cell Carcinoma
-
Celldex TherapeuticsTerminatedKidney Neoplasms | Metastatic Renal Cell Carcinoma | Ovarian Clear Cell Carcinoma | Papillary Renal Cell Carcinoma | Renal Cell Carcinoma (RCC) | Clear-cell Renal Cell CarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Metastatic Clear Cell Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Sarcomatoid Renal Cell Carcinoma | Advanced Renal Cell Carcinoma | Unresectable Renal Cell... and other conditionsUnited States
-
Guru SonpavdePfizer; Hoosier Cancer Research NetworkWithdrawnKidney Cancer | Clear-cell Renal Cell Carcinoma | RCC | Clear-cell Kidney CarcinomaUnited States
-
Peloton Therapeutics, Inc.Active, not recruitingA Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)Kidney Cancer | Clear Cell Renal Cell Carcinoma | Glioblastoma | Solid Tumor | Glioblastoma Multiforme | Advanced Solid Tumors | GBM | Solid Tumor, Adult | Solid Carcinoma | Glioblastoma, Adult | ccRCC | RCC, Clear Cell Adenocarcinoma | RCC | Renal Cell Carcinoma, Metastatic | Renal Cell Carcinoma Recurrent | Renal Cell...
-
Queen Mary University of LondonAstraZeneca; Vall d'Hebron Institute of OncologyActive, not recruitingRenal Clear Cell Carcinoma | Renal Papillary Cell CarcinomaUnited Kingdom
-
AmgenCompletedRenal Cell Carcinoma | Clear Cell Renal Cell Carcinoma | Clear Cell Renal Carcinoma | Renal Cell AdenocarcinomaFrance, United States, Germany
-
Association Pour La Recherche des Thérapeutiques...CompletedClear-cell Metastatic Renal Cell Carcinoma | Clear-cell Renal CarcinomaFrance
-
Mabwell (Shanghai) Bioscience Co., Ltd.Not yet recruitingAdvanced Clear Cell Renal Cell Carcinoma
-
University of WashingtonMerck Sharp & Dohme LLC; Prometheus LaboratoriesTerminatedMetastatic Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer | Advanced Clear Cell Renal Cell Carcinoma | Stage IV Renal Cell CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)RecruitingMetastatic Clear Cell Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8United States